104 related articles for article (PubMed ID: 1445752)
21. In vitro investigations on the antineoplastic effect of hexadecylphosphocholine.
Yanapirut P; Berger MR; Reinhardt M; Schmähl D
Arzneimittelforschung; 1991 Jun; 41(6):652-5. PubMed ID: 1930356
[TBL] [Abstract][Full Text] [Related]
22. Antineoplastic activity and tolerability of a novel heterocyclic alkylphospholipid, D-20133.
Stekar J; Hilgard P; Voegeli R; Maurer HR; Engel J; Kutscher B; Nössner G; Schumacher W
Cancer Chemother Pharmacol; 1993; 32(6):437-44. PubMed ID: 8258191
[TBL] [Abstract][Full Text] [Related]
23. Alkylphosphocholines: influence of structural variation on biodistribution at antineoplastically active concentrations.
Kötting J; Berger MR; Unger C; Eibl H
Cancer Chemother Pharmacol; 1992; 30(2):105-12. PubMed ID: 1600590
[TBL] [Abstract][Full Text] [Related]
24. Antineoplastic activity of sterically stabilized alkylphosphocholine liposomes in human breast carcinomas.
Arndt D; Zeisig R; Eue I; Sternberg B; Fichtner I
Breast Cancer Res Treat; 1997 May; 43(3):237-46. PubMed ID: 9150903
[TBL] [Abstract][Full Text] [Related]
25. Antiproliferation effects of hexadecylphosphocholine on solid tumour and leukaemia selectively in vitro.
Wang YZ; Liu XY; Wu LJ; Zhang YB; Hou L; Xu QS
Drugs Exp Clin Res; 1997; 23(3-4):97-102. PubMed ID: 9403269
[TBL] [Abstract][Full Text] [Related]
26. Antineoplastic activity of alkylphosphocholines (APC) in human breast carcinomas in vivo and in vitro; use of liposomes.
Fichtner I; Zeisig R; Naundorf H; Jungmann S; Arndt D; Asongwe G; Double JA; Bibby MC
Breast Cancer Res Treat; 1994; 32(3):269-79. PubMed ID: 7865855
[TBL] [Abstract][Full Text] [Related]
27. Antitumor effects of erucylphosphocholine on brain tumor cells in vitro and in vivo.
Erdlenbruch B; Jendrossek V; Marx M; Hunold A; Eibl H; Lakomek M
Anticancer Res; 1998; 18(4A):2551-7. PubMed ID: 9703909
[TBL] [Abstract][Full Text] [Related]
28. Hexadecylphosphocholine inhibits phosphatidylinositol and phosphatidylcholine phospholipase C in human leukemia cells.
Berkovic D; Goeckenjan M; Lüders S; Hiddemann W; Fleer EA
J Exp Ther Oncol; 1996 Sep; 1(5):302-11. PubMed ID: 9414418
[TBL] [Abstract][Full Text] [Related]
29. Differential regulation of phospholipase A2 in human leukemia cells by the etherphospholipid analogue hexadecylphosphocholine.
Berkovic D; Lüders S; Goeckenjan M; Hiddemann W; Fleer EA
Biochem Pharmacol; 1997 Jun; 53(11):1725-33. PubMed ID: 9264326
[TBL] [Abstract][Full Text] [Related]
30. Modulation of phospholipase D by hexadecylphosphorylcholine: a putative novel mechanism for its antitumoral activity.
Lucas L; Hernández-Alcoceba R; Penalva V; Lacal JC
Oncogene; 2001 Mar; 20(9):1110-7. PubMed ID: 11314048
[TBL] [Abstract][Full Text] [Related]
31. Growth inhibition of human mammary carcinoma by liposomal hexadecylphosphocholine: Participation of activated macrophages in the antitumor mechanism.
Eue I
Int J Cancer; 2001 May; 92(3):426-33. PubMed ID: 11291082
[TBL] [Abstract][Full Text] [Related]
32. The development of alkylphosphocholines as signal transduction inhibitors: experimental and clinical challenges.
Hilgard P; Pohl J; Engel J
J Cancer Res Clin Oncol; 1997; 123(5):286-7. PubMed ID: 9201252
[TBL] [Abstract][Full Text] [Related]
33. The phospholipid analogue, hexadecylphosphocholine, inhibits protein kinase C in vitro and antagonises phorbol ester-stimulated cell proliferation.
Geilen CC; Haase R; Buchner K; Wieder T; Hucho F; Reutter W
Eur J Cancer; 1991; 27(12):1650-3. PubMed ID: 1782078
[TBL] [Abstract][Full Text] [Related]
34. Effect of miltefosine on transplanted methylnitrosourea-induced mammary carcinoma growing in Fischer 344 rats.
Reinhardt M; Heyl P; Amelung F; Berger MR
Arzneimittelforschung; 1992 Oct; 42(10):1239-42. PubMed ID: 1282010
[TBL] [Abstract][Full Text] [Related]
35. Effects of hexadecylphosphocholine on thrombocytopoiesis.
Berkovic D; Bensch M; Bertram J; Wille T; Haase D; Binder C; Fleer EA
Eur J Cancer; 2001 Mar; 37(4):503-11. PubMed ID: 11267861
[TBL] [Abstract][Full Text] [Related]
36. Cytotoxic effects of hexadecylphosphocholine in neoplastic cell lines including drug-resistant sublines in vitro.
Danhauser-Riedl S; Himmelmann A; Steinhauser G; Busch R; Vogler WR; Rastetter J; Berdel WE
J Lipid Mediat; 1990; 2(5):271-80. PubMed ID: 2133272
[TBL] [Abstract][Full Text] [Related]
37. Morphological and immunological observations on the effects of hexadecylphosphocholine (HPC) in nude mice bearing MT-1 breast cancer xenografts.
Safa O; Parkin SM; Matthew AM; Bibby MC
Anticancer Res; 1997; 17(1A):37-43. PubMed ID: 9066628
[TBL] [Abstract][Full Text] [Related]
38. Hexadecylphosphocholine: determination of serum concentrations in rats.
Unger C; Fleer E; Damenz W; Hilgard P; Nagel G; Eibl H
J Lipid Mediat; 1991; 3(1):71-8. PubMed ID: 1768841
[TBL] [Abstract][Full Text] [Related]
39. New cytostatics--more activity and less toxicity.
Berger MR; Richter H; Seelig MH; Eibl H; Schmähl D
Cancer Treat Rev; 1990 Sep; 17(2-3):143-54. PubMed ID: 2272030
[No Abstract] [Full Text] [Related]
40. New pharmaceuticals: miltefosine.
Hilgard P
Anticancer Drugs; 1990 Dec; 1(2):185. PubMed ID: 2131052
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
